RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients - Kachnic, L A; Pugh, S L; Tai, P (Prostate Cancer Prostatic Dis, 2013)
et al.